NEW White Paper - Companion Diagnostic Development: An Overview Primary Human Mast Cells are Now Available Discovery's Contribution to AR Microscopy Study Featured in Nature Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments NEW Video - Advancing In Vitro Disease Modeling with Mouse Hepatocytes for Gene Therapy

Concordance Study Services

Fast-track concordance studies with our reliable biomarker services and Health Institution status.

Concordance studies are critical to successfully complete and select appropriate biomarkers for clinical trials and diagnostic development. Discovery has built a robust solution integrating the largest commercial biorepository with expert
multi-omic services to accelerate concordance studies cost-effectively.

Advantages of Discovery’s Concordance Study Services

Clinical Specimens

Direct access to the world’s largest commercial biorepository.

Expertise

Decades of experience developing and validating companion diagnostics for leading biotech and pharma clients.

Technology

A technology agnostic approach to enable an unbiased selection of the most suitable platforms.

Compliance & Quality

Specialty testing in CLIA-certified, CAP accredited, and GCLP compliant service laboratories to support concurrent clinical trials and regulatory submissions.

Global Harmonization

Global standardization and harmonization of IHC assays via our Biomarker Academy™ training programs and post-approval services.

Capacity

One of the largest commercial fleets of proteomics, genomics, and molecular pathology instruments –
all under one roof and laboratories on different continents to speed testing.

Technologies

We routinely conduct concordance testing using our diverse, platform agnostic capabilities spanning the following technologies.

Genomics

Proteomics

Flow Cytometry

Molecular Pathology

Roche / Ventana: Benchmark Discovery, benchmark Ultra
Leica: Bond III
Dako / Agilent: Omnis, Bond RX, Bond III, Aperio AT2
Nanostring: Ncounter
Techmate
Akoya

Contact Us Today

Privacy Settings

Concordance Study Services

Advantages of Discovery’s Concordance Study Services

Clinical Specimens

Expertise

Technology

Compliance & Quality

Global Harmonization

Capacity

Technologies

Genomics

Proteomics

Flow Cytometry

Molecular Pathology

Contact Us Today

Gentest Services

MARKETS WE SERVE

COMPANY

Markets We Serve

Resources

Popular Keywords

Categories,Pages

Quick Links

Technologies

Development and Clinical Trial Solutions

Our Mission

Technologies

Development and ClinicalTrial Solutions

Post-Approval Services

Development and Clinical
Trial Solutions

Development and Clinical
Trial Solutions